Search Results - "Brys, M"

Refine Results
  1. 1

    Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease by MOSCONI, L, MISTUR, R, SWITALSKI, R, BRYS, M, GLODZIK, L, RICH, K, PIRRAGLIA, E, TSUI, W, DE SANTI, S, DE LEON, M. J

    Published in Neurology (10-02-2009)
    “…At cross-section, cognitively normal individuals (NL) with a maternal history of late-onset Alzheimer disease (AD) have reduced glucose metabolism (CMRglc) on…”
    Get full text
    Journal Article
  2. 2

    Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease by De LEON, M. J., MOSCONI, L., BLENNOW, K., DeSANTI, S., ZINKOWSKI, R., MEHTA, P. D., PRATICO, D., TSUI, W., LOUIS, L. A. SAINT, SOBANSKA, L., BRYS, M., LI, Y., RICH, K., RINNE, J., RUSINEK, H.

    Published in Annals of the New York Academy of Sciences (01-02-2007)
    “…:  It is widely believed that the path to early and effective treatment for Alzheimer's disease (AD) requires the development of early diagnostic markers that…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Expression of vascular endothelial growth factor and its correlation with clinical symptoms and endoscopic findings in patients with chronic radiation proctitis by Trzcinski, R., Dziki, A., Brys, M., Moszynska‐Zielinska, M., Chalubinska‐Fendler, J., Mik, M., Kujawski, R., Dziki, L.

    Published in Colorectal disease (01-04-2018)
    “…Aim The aim of this study was to assess the expression of vascular endothelial growth factor (VEGF) as a key proangiogenic factor and determine whether there…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Small Fiber Dysfunction Predominates in Fabry Neuropathy by Dütsch, M, Marthol, H, Stemper, B, Brys, M, Haendl, T, Hilz, M.J

    Published in Journal of clinical neurophysiology (01-12-2002)
    “…SUMMARYFabry disease is an X-linked recessive disease with a reduction of lysosomal α galactosidase A and consecutive storage of glycolipids e.g., in the…”
    Get full text
    Journal Article
  7. 7

    Longitudinal CSF isoprostane and MRI atrophy in the progression to AD by DE LEON, M. J, MOSCONI, L, GLODZIK, L, SWITALSKI, R, SAINT LOUIS, L. A, PRATICO, D, LI, J, DE SANTI, S, YAO, Y, TSUI, W. H, PIRRAGLIA, E, RICH, K, JAVIER, E, BRYS, M

    Published in Journal of neurology (01-12-2007)
    “…Very little data exist to evaluate the value of longitudinal CSF biological markers for Alzheimer's disease (AD). Most studies indicate that tau and amyloid…”
    Get full text
    Journal Article
  8. 8

    Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder by Chahine, L. M., Iranzo, A., Fernández-Arcos, A., Simuni, T., Seedorff, N., Caspell-Garcia, C., Amara, A. W., Comella, C., Högl, B., Hamilton, J., Marek, K., Mayer, G., Mollenhauer, B., Postuma, R., Tolosa, E., Trenkwalder, C., Videnovic, A., Oertel, W.

    Published in NPJ Parkinson's Disease (29-01-2019)
    “…REM sleep behavior disorder (RBD) is strongly associated with development of Parkinson’s Disease and other α-synuclein-related disorders. Dopamine transporter…”
    Get full text
    Journal Article
  9. 9

    The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma by Starska, K, Forma, E, Bryś, M, Głowacka, E, Lewy-Trenda, I, Łukomski, M, Krajewska, WM

    Published in Advances in medical sciences (01-06-2012)
    “…The aim of this study was to analyze of TLRs mRNA expression in peripheral blood mononuclear cells as potential biomarkers of neoplastic lesions progress and…”
    Get full text
    Journal Article
  10. 10

    Androgens and androgen receptor: do they play a role in breast cancer? by Bryś, M

    Published in Medical science monitor (01-03-2000)
    “…Although the role of androgens and AR in breast cancer genesis, development of breast cancer and tumor responsiveness to endocrine therapies is poorly…”
    Get more information
    Journal Article
  11. 11

    2-Deoxy-d-Glucose (2-DG)–Induced Cardiac Toxicity in Rat: NT-proBNP and BNP as Potential Early Cardiac Safety Biomarkers by Terse, P. S., Joshi, P. S., Bordelon, N. R., Brys, A. M., Patton, K. M., Arndt, T. P., Sutula, T. P.

    Published in International journal of toxicology (01-05-2016)
    “…2-Deoxy-d-glucose (2-DG) is being developed as a potential anticonvulsant and disease-modifying agent for patients with epilepsy; however, during preclinical…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy by Hilz, M J, Brys, M, Marthol, H, Stemper, B, Dütsch, M

    Published in Neurology (13-04-2004)
    “…Peripheral neuropathy in Fabry disease predominantly involves small nerve fibers. Recently, enzyme replacement therapy (ERT) with recombinant human…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Communication Challenges in the WC3's Web Content Accessibility Guidelines by BRYS, CATHERINE M., VANDERBAUWHEDE, WIM

    Published in Technical communication (Washington) (01-02-2006)
    “…♦ Analyzes the November 2004 working draft of the Web Content Accessibility Guidelines 2.0 ♦ Recommends ways to make the guidelines more comprehensible to…”
    Get full text
    Journal Article
  18. 18

    Correlation between power Doppler ultrasonography and clinical severity in Achilles tendinopathy by PEERS, Koen H. E, BRYS, Peter P. M, LYSENS, Roeland J. J

    Published in International orthopaedics (2003)
    “…Twenty-five patients with chronic Achilles tendinopathy were clinically and ultrasonographically evaluated. A positive correlation existed between power…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Clonidine improves postprandial baroreflex control in familial dysautonomia by Marthol, H., Tutaj, M., Brys, M., Brown, C. M., Hecht, M. J., Berlin, D., Axelrod, F. B., Hilz, M. J.

    Published in European journal of clinical investigation (01-10-2003)
    “…Background  Patients with familial dysautonomia (FD) frequently experience hypertensive crises after gastrostomy feeding. The central α2‐agonist clonidine…”
    Get full text
    Journal Article